OTC · WXXWY
Healthcare · Biotechnology
$12.04
Up+$0.08 (+0.67%)
Updated Sep 11, 2026, 4:58 PM
SID Score
5.5/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
WXXWY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning WXXWY.
WXXWY research
Company profile and research snapshot.
WUXI BIOLOGICS UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Aug 27, 2026
WuXi Biologics (Cayman) Inc. (WXXWY) Q2 2026 Earnings Call August 26, 2026 8:00 AM EDTCompany ParticipantsChris Chen - CEO & Executive DirectorMing Tu -...
SeekingAlpha · Aug 26, 2026
2026-08-26. The following slide deck was published by WuXi Biologics (Cayman) Inc.
Yahoo · Aug 25, 2026
WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for biologics discovery, development and manufacturing, is pleased to announce its unaudited interim results for the first half of 2026 ("Reporting Period").
Yahoo · Jul 29, 2026
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has been included in the FTSE4Good Index Series in recognition of its outstanding sustainability performance, marking the sixth consecutive year the company has received this distinction. The inclusion further underscores WuXi Biologics' long-term leadership in Environmental, Social and Governance (ESG) and highlights the Company's ability to consistently cre
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning WXXWY.
